Basic information Safety Supplier Related

(+)-BICUCULLINE METHOCHLORIDE

Basic information Safety Supplier Related

(+)-BICUCULLINE METHOCHLORIDE Basic information

Product Name:
(+)-BICUCULLINE METHOCHLORIDE
Synonyms:
  • 1(s),9(r)-(-)-bicuculline methochloride
  • 1(S),9(R)-(-)-Bicuculline methchloride
  • (+)-BICUCULLINE METHOCHLORIDE
CAS:
38641-83-7
MF:
C21H20NO6.Cl
MW:
417.843
Product Categories:
  • AntagonistsCell Signaling and Neuroscience
  • GABAergics
  • Neurotransmission
  • Neurotransmitters
  • New Products
Mol File:
38641-83-7.mol
More
Less

(+)-BICUCULLINE METHOCHLORIDE Chemical Properties

storage temp. 
2-8°C
solubility 
H2O: >10mg/mL
form 
powder
color 
Green
Water Solubility 
Soluble in water (100mM)
More
Less

Safety Information

Safety Statements 
24/25
RIDADR 
UN 1544 6.1/PG 2
WGK Germany 
3
More
Less

(+)-BICUCULLINE METHOCHLORIDE Usage And Synthesis

Uses

Bicuculline ((+)-Bicuculline; d-Bicuculline) methochloride is a selective GABAA receptor antagonist with an IC50 value of 3 μM. Bicuculline methochloride induces clonic tonic convulsions in mammals and can also be used to block Ca2+ activated potassium channels. Bicuculline methochloride can be used in studies of epilepsy and other related psychiatric disorders[1][2].

Biochem/physiol Actions

1(S),9(R)-(?)-Bicuculline methchloride is a GABAA receptor antagonist, which blocks Ca2+-activated potassium (SK) channels.

in vivo

Bicuculline methochloride can be used in animal modeling to create epilepsy models. Intracerebral injection of Bicuculline methochloride causes an increase in capillary blood flow in the epileptic focus (the specific region where seizures originate), with local blood flow increasing to 42.5 red blood cells per second (compared to 27.8 red blood cells per second in areas away from the epileptic focus)[5].

Induction of epilepsy[5]
Background
Epileptic seizures are closely related to the imbalance between neuronal excitability and inhibition, leading to abnormal neuronal discharges. Bicuculline methochloride is a GABAA receptor (GABAA receptor) antagonist that can inhibit inhibitory neurotransmission, induce excitatory neuronal activity, and cause population bursts (indicating that a large number of neurons fire action potentials simultaneously), thereby inducing epileptic seizures[5].
Specific Modeling Methods
Mice: C57BL6 ? male and female ? 20-30 g
Administration: 2.5 mM ? Intracranial Injection (deep layers of the somatosensory cortex) ? single dose
Note
(1) Dissolve 2.5 mM bicuculline methochloride in physiological saline.
(2) Inject bicuculline methochloride by inserting a glass micropipette with a diameter of 20-50 μm into the deep layers of the mouse somatosensory cortex.
(3) Surgical operation precautions:
a. Fix an insulated metallic head frame above the planned craniotomy area, and make a craniotomy with a diameter of approximately 3 mm over the mouse somatosensory cortex, removing the dura mater to expose the brain tissue.
b. Gently rinse the exposed area with artificial cerebrospinal fluid (composition of artificial cerebrospinal fluid: 125 mM NaCl, 3 mM KCl, 26 mM NaHCO3, 10 mM glucose, 1.1 mM NaH2PO4, 2 mM CaCl2, 1 mM MgSO4) to maintain the physiological environment of the brain tissue.
c. Cover the craniotomy with a phosphate-buffered saline solution containing 1% agarose (pH 7.4) and place a glass coverslip on the metal frame to protect the exposed brain tissue.
Modeling Indicators
Electrophysiological changes: A large number of neurons in the deep layers of the mouse somatosensory cortex fire electrical signals simultaneously, producing electrical signals characterized by interictal spikes (Note: Interictal Spikes (IISs) refer to the brief, high-amplitude voltage deflections observed in the electroencephalogram (EEG), which are typically associated with epileptic seizures).
Blood flow changes: In the somatosensory cortex of mice injected with bicuculline methochloride, capillary blood flow significantly increases.
Correlated Product(s): /
Opposite Product(s): /

storage

Room temperature

References

[1] Y Yajima, et al. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res. 2000 Apr 17;862(1-2):120-6. DOI:10.1016/s0006-8993(00)02096-5
[2] W A Turski, et al. Excitatory amino acid antagonists protect mice against seizures induced by bicuculline. Brain Res. 1990 Apr 23;514(1):131-4. DOI:10.1016/0006-8993(90)90444-g
[3] Huang SH, et al. Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors. Eur J Pharmacol. 2003;464(1):1-8. DOI:10.1016/s0014-2999(03)01344-x
[4] Khawaled R, et al. Bicuculline block of small-conductance calcium-activated potassium channels. Pflugers Arch. 1999 Aug;438(3):314-21. DOI:10.1007/s004240050915
[5] Hirase H, et al. Capillary level imaging of local cerebral blood flow in bicuculline-induced epileptic foci. Neuroscience. 2004;128(1):209-16. DOI:10.1016/j.neuroscience.2004.07.002

(+)-BICUCULLINE METHOCHLORIDESupplier

Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Nantong QuanYi Biotechnology Co., Ltd
Tel
0513-66337626 18051384581
Email
sales@chemhifuture.com
Shanghai Fine Biotech Co.，Ltd
Tel
18221172427
Email
sale@fine-biotech.com
Chengdu Peter-like Biotechnology Co., Ltd.
Tel
028-81700200 13308200041
Email
2851167782@qq.com